- Home
- INDP vs ALCE Comparison
INDP vs ALCE Comparison
Compare INDP & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- ALCE
- Stock Information
- Founded
- INDP 2000
- ALCE 2019
- Country
- INDP United States
- ALCE United States
- Employees
- INDP N/A
- ALCE N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- INDP Health Care
- ALCE Utilities
- Exchange
- INDP Nasdaq
- ALCE Nasdaq
- Market Cap
- INDP 10.2M
- ALCE 3.7M
- IPO Year
- INDP N/A
- ALCE N/A
- Fundamental
- Price
- INDP $0.84
- ALCE $0.90
- Analyst Decision
- INDP Strong Buy
- ALCE
- Analyst Count
- INDP 2
- ALCE 0
- Target Price
- INDP $8.50
- ALCE N/A
- AVG Volume (30 Days)
- INDP 22.1K
- ALCE 76.2K
- Earning Date
- INDP 11-12-2024
- ALCE 11-19-2024
- Dividend Yield
- INDP N/A
- ALCE N/A
- EPS Growth
- INDP N/A
- ALCE N/A
- EPS
- INDP N/A
- ALCE N/A
- Revenue
- INDP N/A
- ALCE N/A
- Revenue This Year
- INDP N/A
- ALCE N/A
- Revenue Next Year
- INDP N/A
- ALCE N/A
- P/E Ratio
- INDP N/A
- ALCE N/A
- Revenue Growth
- INDP N/A
- ALCE N/A
- 52 Week Low
- INDP $0.81
- ALCE $0.74
- 52 Week High
- INDP $3.10
- ALCE $38.50
- Technical
- Relative Strength Index (RSI)
- INDP 33.67
- ALCE 33.57
- Support Level
- INDP $0.81
- ALCE $0.81
- Resistance Level
- INDP $1.01
- ALCE $0.84
- Average True Range (ATR)
- INDP 0.06
- ALCE 0.11
- MACD
- INDP -0.00
- ALCE 0.05
- Stochastic Oscillator
- INDP 10.36
- ALCE 32.24
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.